FORCE Blog

This blog will cover topics of interest that affect our community. Unless otherwise stated, the blog articles will be written by Sue Friedman, Executive Director of FORCE.

| More

KNOW MORE

September 16, 2019

The Gift of More Options

by Tanya Temkin Note: In honor of Ovarian Cancer Awareness Month, FORCE is partnering with AstraZeneca to raise awareness of genetic testing for women who are diagnosed with ovarian cancer. FORCE volunteer Tanya Temkin shares her personal story of how genetic testing affected her treatment options. Two and a half years ago, my friend Marcie … + read more

February 28, 2018

Five Year Ovarian Cancerversary

by Cindy McKinnon Deurloo Five years ago I heard the only words a cancer patient wants to hear “you’re cancer free and in remission.” After the painful surgery (radical hysterectomy), surgical menopause, 6 rounds of aggressive chemotherapy that made me very ill, multiple blood transfusions, hospital stays and scars, I made it!! How blessed am I to … + read more

October 12, 2017

Patients Weigh In On Review of PARP Inhibitors for Treatment of Ovarian Cancer

by Jill Holdren Last month on September 14th, Lisa Schlager, FORCE VP of Public Policy, and I went to St. Louis, Missouri to give comments at the Institute for Clinical and Economic Review’s (ICER)[1] meeting on the clinical effectiveness and value of PARP inhibitors in the treatment of ovarian cancer. The meeting was one of … + read more

July 25, 2017

Why I Asked My Mom to Undergo Genetic Testing After Her Ovarian Cancer Diagnosis

by Lisa Rezende, PhD When my mom was first diagnosed with ovarian cancer at the age of 55 in 2001, there were many reasons why she didn’t pursue genetic testing. National guidelines didn’t automatically recommend genetic counseling and/or testing. My family history was limited. While my grandmother had breast cancer, she was diagnosed after menopause, … + read more

May 3, 2017

Genetic Testing Informs Important Medical Decisions for Three Generations in a Family

When Holly Jonas of Long Island, NY learned that her mother had been diagnosed with ovarian cancer at the age of 79, it felt like déjà vu. Her mom, who has a BRCA1 gene mutation, was already a cancer survivor, having been diagnosed with breast cancer at age 48. Believing that “knowledge is power,” Holly … + read more

March 30, 2017

Genetic Testing Results In An Early Stage Ovarian Cancer Diagnosis

After discovering that her mother carried the BRCA1 mutation, Ilana Feuchter of Vienna, Virginia decided to get tested as well, a decision that would ultimately lead to her diagnosis of Stage 2 ovarian cancer in November of 2013. Ilana’s journey began in the Spring of 2013 after her mother was diagnosed with a cancer of … + read more

January 19, 2017

My Experience with Ovarian Cancer: Surprise, Shock, Genetic Testing and Survival by Corinne Florin

When I got my diagnosis of stage IIIa, grade 3, clear cell ovarian cancer, it was such a shock that not a lot of information sunk in. I may or may not have discussed genetic testing but I just don’t remember.  I was aware that genetic testing existed, but during my recovery and subsequent treatment … + read more

Connect with others.

Call our Helpline

Our helpline offers peer support for people concerned about hereditary cancer. All calls are confidential. Call any time.

Join a Local Group

FORCE has outreach groups throughout the United States and in Essex, United Kingdom that meet periodically to offer peer support, and share resources.

FORCE:Facing Our Risk of Cancer Empowered